Non-Current Assets
Intangibles (Net)
Eli Lilly Intangibles (Net) increased by 13.1% to $7.37B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.7%, from $6.01B to $7.37B. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows a downward trend with a -2.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
Detailed definition
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Peer comparison
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
Metric ID:
intangible_assets_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.99B | $7.89B | $7.69B | $7.48B | $7.50B | $7.12B | $7.21B | $7.09B | $6.90B | $6.78B | $6.91B | $6.76B | $6.64B | $6.54B | $6.17B | $6.01B | $5.91B | $6.45B | $6.52B | $7.37B |
| QoQ Change | — | -1.2% | -2.5% | -2.7% | +0.2% | -5.0% | +1.2% | -1.7% | -2.6% | -1.8% | +1.8% | -2.1% | -1.9% | -1.5% | -5.7% | -2.5% | -1.7% | +9.1% | +1.2% | +13.1% |
| YoY Change | — | — | — | — | -6.1% | -9.7% | -6.3% | -5.3% | -7.9% | -4.8% | -4.2% | -4.6% | -3.9% | -3.6% | -10.7% | -11.1% | -11.0% | -1.4% | +5.8% | +22.7% |
Range$5.91B – $7.99B
CAGR-1.7%
Avg YoY Growth-3.9%
Median YoY Growth-5.0%
Current Streak3 quarters growth
Intangibles (Net) at Other Companies
Frequently Asked Questions
- What is Eli Lilly's intangibles (net)?
- Eli Lilly (LLY) reported intangibles (net) of $7.37B in Q1 2026.
- How has Eli Lilly's intangibles (net) changed year-over-year?
- Eli Lilly's intangibles (net) increased by 22.7% year-over-year, from $6.01B to $7.37B.
- What is the long-term trend for Eli Lilly's intangibles (net)?
- Over 5 years (2020 to 2025), Eli Lilly's intangibles (net) has grown at a -2.6% compound annual growth rate (CAGR), from $7.45B to $6.52B.
- What does intangibles (net) mean?
- The value of non-physical assets like patents and brands after accounting for amortization.